Philippe Rouanet
Philippe Rouanet is an expert in Surgery at Institut du Cancer de Montpellier (France). As of October 2026, ScienceLeadR ranks Philippe Rouanet in the top 1% of experts worldwide for Rectal Diseases, Intestinal Neoplasms and Gastrointestinal Neoplasms. Philippe Rouanet has authored 370 publications, the most recent in 2026, and is an investigator in 32 clinical trials, 6 of them ongoing. SLR score: 1,342 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Oncology - Gastroenterology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1991 - 2026
Number : 370
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 32
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Safety Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum NCT06236633 — injections, pilot projects, telephone, pilots, fistula, safety, blood, absenteeism, hematoma, radiologists, neoplasms, mesenteric artery, superior, colon, arteries, rectum, radiology, mesenteric arteries, rectal neoplasms, research, ischemic preconditioning, punctures, mesenteric artery, inferior, ischemia, radiology, interventional, surgeons | N/A | Recruiting | 2024 |
| Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer NCT06123156 — radiotherapy, neoplasms, rehabilitation, sildenafil citrate, rectum, proctectomy, rectal neoplasms, blood platelets | Phase 3 | Recruiting | 2025 |
| Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17) NCT05233787 — quality of life, neoplasms, enema, sepsis, rectal neoplasms, anastomotic leak, ileostomy | N/A | Recruiting | 2022 |
| Study Evaluating the Tailored Management of Locally advanced Rectal Carcinoma NCT04749108 — radiotherapy, intensity-modulated, radiotherapy, induction chemotherapy, radiologists, neoplasms, drug therapy, oxaliplatin, proctectomy, chemoradiotherapy, rectal neoplasms, morbidity, therapeutics, software, capecitabine, laparotomy, irinotecan, chemotherapy, carcinoma | Phase 2/Phase 3 | Recruiting | 2021 |
| Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex TCM Parietal Prosthesis Versus Without Mesh NCT04282473 — hernia, epidemiology, colostomy | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map